AusPAR: Tivicay and Tivicay PD

Australian Public Assessment Report

AusPAR

AusPAR: Tivicay and Tivicay PD [PDF, 430.31 KB]

AusPAR: Tivicay and Tivicay PD [Word, 164.5 KB]

Attachment-Product information for Tivicay and Tivicay PD [PDF, 398.21 KB]

Attachment-Product information for Tivicay and Tivicay PD [Word, 124.69 KB]

Device/Product Name

Tivicay and Tivicay PD

Active ingredients

Dolutegravir (as sodium)

AusPAR Date

5 July 2022

Published

1 August 2022

Submission Number

PM-2020-03495-1-2

Submission Type

Extension of indications, and new dose form

Decision

Approved